Related Experiment Video
Updated: Nov 11, 2025
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
An Integrated Clinical and Genetic Prediction Model for Tacrolimus Levels in Pediatric Solid Organ Transplant
Sandar Min1, Tanya Papaz1, A Nicole Lambert2
1Genetics and Genome Biology Program, Hospital for Sick Children, Toronto, ON, Canada.
Insights
This study developed a model to predict tacrolimus levels in pediatric solid organ transplant recipients. Combining clinical factors with genetic data improved prediction accuracy for personalized immunosuppression management.
Area of Science:
- Pharmacogenomics
- Transplantation Medicine
- Genetics
Background:
- Achieving and maintaining therapeutic tacrolimus levels is challenging in solid organ transplantation (SOT).
- Tacrolimus is a critical immunosuppressant following SOT.
- Predicting drug levels is essential for effective patient management.
Purpose of the Study:
- To develop an integrated clinical and genetic prediction model for tacrolimus levels in pediatric SOT patients.
- To identify key genetic and clinical factors influencing tacrolimus pharmacokinetics.
- To improve individualized dosing strategies for tacrolimus.
Main Methods:
- A multicenter prospective observational cohort study included pediatric SOT recipients (<18 years).
- Genome-wide genotyping using SNP arrays was performed on 455 patients (discovery) and 322 (validation).
- Association analysis correlated single nucleotide polymorphisms (SNPs) with tacrolimus trough levels over 1 year.
Main Results:
- Genome-wide association study identified 14 independently associated SNPs with tacrolimus levels.
- Clinical factors (organ type, age) and specific SNPs (rs776746, rs12333983, rs12957142) were top predictors.
- The combined clinical-genetic model explained 30% of tacrolimus level variation, outperforming clinical (18%) or genetic (12%) models alone.
Conclusions:
- Integrating age, organ type, and genotype significantly improves tacrolimus level prediction in pediatric SOT.
- This study provides a foundation for developing individualized, genotype-guided tacrolimus dosing algorithms.
- Personalized medicine approaches are crucial for optimizing immunosuppression post-transplant.
Background:
There are challenges in achieving and maintaining therapeutic tacrolimus levels after solid organ transplantation (SOT). The purpose of this genome-wide association study was to generate an integrated clinical and genetic prediction model for tacrolimus levels in pediatric SOT.
Methods:
In a multicenter prospective observational cohort study (2015-2018), children <18 years old at their first SOT receiving tacrolimus as maintenance immunosuppression were included (455 as discovery cohort; 322 as validation cohort). Genotyping was performed using a genome-wide single nucleotide polymorphism (SNP) array and analyzed for association with tacrolimus trough levels during 1-y follow-up.
Results:
Genome-wide association study adjusted for clinical factors identified 25 SNPs associated with tacrolimus levels; 8 were significant at a genome-wide level (P < 1.025 × 10-7). Nineteen SNPs were replicated in the validation cohort. After removing SNPs in strong linkage disequilibrium, 14 SNPs remained independently associated with tacrolimus levels. Both traditional and machine learning approaches selected organ type, age at transplant, rs776746, rs12333983, and rs12957142 SNPs as the top predictor variables for dose-adjusted 36- to 48-h posttacrolimus initiation (T1) levels. There was a significant interaction between age and organ type with rs776476*1 SNP (P < 0.05). The combined clinical and genetic model had lower prediction error and explained 30% of the variation in dose-adjusted T1 levels compared with 18% by the clinical and 12% by the genetic only model.
Conclusions:
Our study highlights the importance of incorporating age, organ type, and genotype in predicting tacrolimus levels and lays the groundwork for developing an individualized age and organ-specific genotype-guided tacrolimus dosing algorithm.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:28Kidney Transplant I: Introduction
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant